4th International Congress on Myeloproliferative Diseases and Myelodysplastic Syndromes

Ultima Vez Modificado: 12 de octubre del 2007

Share article


Conference Dates: November 8-10, 2007
Conference Location: New York, New York USA

Sponsoring Group: Imedex

Conference Web Page URL: Imedex.com

Conference Objectives: MDS and MPD

Who Should Attend: hematologists, oncologists, internists, other physicians, physicians-in-training, and healthcare professionals (nurses and pharmacists)

Conference Agenda:

Registration Information: Register online at www.imedex.com or call +1(678)242-0906

Conference Fees: $399.00

Continuing Education: Yes

Miscellany: 17.25 of AMA PRA Category 1 Credits


News
Adjuvant Zoledronic Acid Not Beneficial in Breast Cancer

Sep 27, 2011 - For patients with early-stage breast cancer, the addition of zoledronic acid to standard adjuvant therapy does not offer any benefit for disease-free or overall survival, according to a study published in the New England Journal of Medicine to coincide with presentation at the 2011 European Multidisciplinary Cancer Congress, held from Sept. 23 to 27 in Stockholm, Sweden.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información